MRK investigational once-weekly oral hiv treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with h

MRK investigational once-weekly oral hiv treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with hiv who switched antiretroviral therapy